Evidence map›Paper›PMID 32797298›Full record

ArticleJournal of neurology2021

Early epileptic seizures in ischaemic stroke treated by mechanical thrombectomy: influence of rt-PA.

Khadija Ba, Barbara Casolla, François Caparros, Nicolas Bricout, Lucie Della Schiava, Marco Pasi, Nelly Dequatre-Ponchelle, Marie Bodenant, Régis Bordet, Charlotte Cordonnier and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Khadija BaDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.
Barbara CasollaDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.
François CaparrosDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.
Nicolas BricoutDepartment of Neuroradiology, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.
Lucie Della SchiavaDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.
Marco PasiDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.ORCID http://orcid.org/0000-0001-9976-2459
Nelly Dequatre-PonchelleDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.
Marie BodenantDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.
Régis BordetDepartment of Pharmacology, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.ORCID http://orcid.org/0000-0003-3916-6422
Charlotte CordonnierDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.ORCID http://orcid.org/0000-0002-5697-6892
Hilde HénonDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France.ORCID http://orcid.org/0000-0001-6274-7562
Didier LeysDepartment of Neurology (Stroke Unit), Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, University of Lille, INSERM (U-1172), CHU Lille, 59000, Lille, France. didier.leys@univ-lille.fr.ORCID http://orcid.org/0000-0003-4408-4392
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe epileptogenicity of recombinant tissue-plasminogen activator (rt-PA) has been suggested, but seizures were not evaluated in randomised controlled trials.

objectiveTo evaluate whether rt-PA was associated with early seizures in a cohort of consecutive patients with cerebral ischaemia.

methodWe included consecutive adults with ischaemic stroke due to large-vessel occlusion from the North-of-France stroke network selected for a mechanical thrombectomy (MT). Patients without contraindication received i.v. rt-PA. We evaluated stroke severity with the National Institutes of Health Stroke Scale (NIHSS), and functional status with the modified Rankin scale (mRS), and recorded epileptic seizures occurring between the end of imaging and day 7. We performed statistics using propensity analyses.

resultsWe included 1638 patients (783 men, 47.8%; median age 71 years; median NIHSS score 16; 1007 treated by rt-PA, 61.5%), in whom 60 (3.7%) developed early epileptic seizures. After adjustment on propensity scores, early seizures were associated with infections [adjusted odds ratio (

conclusionWe found no significant association between rt-PA and early epileptic seizures. If rt-PA has the potential for epileptogenicity, the magnitude of the effect should be modest compared to its favourable effect on functional outcome.

Indexed as

Brain IschemiaIschemic StrokeStrokeAdultAgedFibrinolytic AgentsFranceHumansMaleSeizuresThrombectomyThrombolytic TherapyTissue Plasminogen ActivatorTreatment OutcomeFibrinolytic AgentsTissue Plasminogen ActivatorCerebral ischaemiaEarly epileptic seizuresIschaemic strokeMechanical thrombectomyRecombinant tissue-plasminogen activator

Identifiers

PMID32797298
OpenAlexW3049749021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.